Send me real-time posts from this site at my email

Amylyx’s ALS Drug Is Approved by the FDA

U.S. drug regulators approved Amylyx Pharmaceuticals Inc.’s new drug for amyotrophic lateral sclerosis, or ALS, giving patients a new option for slowing progression of the fatal disease. The drug is the first that the Food and Drug Administration has approved for ALS, also known as Lou Gehrig’s disease, in five years and promises to extend the lives of patients by several months.

Welcome! Is it your First time here?

What are you looking for? Select your points of interest to improve your first-time experience:

Apply & Continue